openPR Logo
Press release

North America will Lead Cardiovascular Monitoring and Diagnostic Devices Market due to High Awareness About Available Diagnosis and Treatment Methods Among Patients and Physicians

04-24-2017 02:38 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

North America will Lead Cardiovascular Monitoring

Global Cardiovascular Monitoring and Diagnostic Devices Market: Overview

The number of deaths due to cardiovascular diseases and their prevalence has been increasing speedily in the last couple of years, thus attracting the attention of government bodies, bio research firms, and healthcare institutions alike. Numerous companies are venturing into the global cardiovascular monitoring and diagnostic devices market with an innovative approach and a range of high-end products for the purpose of treating various cardiovascular ailments. Research and development projects are being taken up by several institutions and there has also been a considerable rise in terms of the funding provided by governments. Furthermore, government organizations are also implementing different health schemes in order to improve the awareness level regarding cardiovascular diseases and reducing their prevalence.

Read the Complete Details for this Market at: http://www.transparencymarketresearch.com/crdiovascular-monitoring-diagnostic-devices.html

The report is an investigation in the growth of the global cardiovascular monitoring and diagnostic devices market over the last couple of years and in the coming years. The market research publication further reasons out the causes of the changes in the market across the globe. It does this so by presenting an evaluation of the dynamics and the trends prevalent from the last few years and the ones that are likely to retain an impact during the forecast period. The Porter’s five forces analysis is being taken into consideration for the analysts to provide a clear view of the vendor landscape to the readers. Mergers, agreements, acquisitions, and other partnerships have also been highlighted in the report. The study further delves into the working of the various leading companies along with the information on the products, strategies, and shares of the companies in question.

Global Cardiovascular Monitoring and Diagnostic Devices Market: Trends and Prospects

With the growing number of people crossing the age of 65, the prevalence of cardiovascular diseases is also magnifying. It has been expected that a huge rise in the geriatric population across the world will trigger the demand for effective and efficient cardiovascular monitoring and diagnostic devices. The impact on the adoption of different varieties of cardiovascular monitoring and diagnostic devices across regions such as the Middle East and Asia Pacific is expected to be humungous due to the flourishing medical tourism sector in the emerging economies of these regions. The growth of the market is expected to be further supplemented by the low cost of procedure and availability of affordable and reliable labor, especially in countries such as Indonesia, China, India, and Turkey. The threat of cardiovascular diseases is also rising due to the prevalence of factors such as growing consumption of alcohol and tobacco, high level of stress, unhealthy food habits, and lack of physical activities. This, in turn, is also warranting the demand for cardiovascular monitoring and diagnostic devices across the globe.

Global Cardiovascular Monitoring and Diagnostic Devices Market: Regional Outlook

North America is expected to emerge as the leading market in the global cardiovascular monitoring and diagnostic devices market owing the favorable reimbursement policies provided by the governments in the region, growing awareness among consumers regarding the availability of treatment and diagnosis methods, and advanced healthcare infrastructure. Europe is likely to closely follow North America due to high incidence of cardiovascular diseases.

Perceive the Sample Report containing the Upcoming Opportunities for this Market at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2385

Global Cardiovascular Monitoring and Diagnostic Devices Market: Vendor Landscape

Some of the leading vendors in the market are Siemens Healthcare, St. Jude Medical Inc., Spacelabs Healthcare, Philips Healthcare, and GE Healthcare.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release North America will Lead Cardiovascular Monitoring and Diagnostic Devices Market due to High Awareness About Available Diagnosis and Treatment Methods Among Patients and Physicians here

News-ID: 512428 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Cardiovascular

Increasing Prevalence of Cardiovascular Diseases to Augment the Cardiovascular I …
Cardiovascular information system offers on-time access to cardiovascular electronic medical records in reports, images, and waveforms, and allows easy report generation and distribution. Cardiovascular information system is extensively used in electrocardiography (ECG) data management, echocardiography, catheterization, and vascular solutions. Click Here To Get Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/20 Cardiovascular information system is used to store, archive, and share healthcare information. It is a unique software solution that helps improve the clinical and financial
Global Cardiovascular Drugs Market
Global Cardiovascular Drugs Market – Industry Analysis and Forecast (2018-2026) – by Drug Class, Indications, Distribution Channels, and Region. Global Cardiovascular Drugs Market was valued at US$ 80.5 Bn in 2017 and is expected to reach US$ 98.8 Bn by 2026, at a CAGR of 2.6 % during the forecast period. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data,
Mexico Cardiovascular Devices Market Outlook to 2025 Cardiac Assist Devices, Car …
Orbisresearch.com has announced the addition of Mexico Cardiovascular Devices Market. The report focuses on global major leading industry players with information such as company profiles, product picture and specification. Mexico Cardiovascular Devices Market Outlook to 2025, provides key market data on the Mexico Cardiovascular Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market categories - Cardiac Assist Devices, Cardiac Rhythm
Cardiovascular Drugs Market | Insights
Some of the common cardiovascular diseases include hypertensive heart disease, rheumatic heart disease, ischemic heart disease, inflammatory heart disease, and cerebrovascular heart disease. Major problems associated with hypertensive heart disease include angina, hypertrophy, and heart failure. These problems are caused due to high blood pressure in the heart’s arteries and muscles, which causes narrowing of arteries and thickening and enlargement of heart. The global cardiovascular drug market is primarily driven
Increasing Cardiovascular Surgeries Leads To Higher Market Value For Cardiovascu …
When a coronary artery is narrowed by the accumulation of fatty acids, also known as plaque, the blood flow to heart is reduced which result in the chest pain and if the blockage increases the blood flow to the heart is further reduced and might lead to cardiac arrest. To reduce the chances of heart attack, a tiny wire mesh tube is inserted in the artery with a balloon catheter,
Cardiovascular Monitoring and Diagnostic Devices Market to be Driven with the Ri …
The global market for cardiovascular monitoring and diagnostic devices is expected to expand at a healthy CAGR of 6.4% over the period between 2016 and 2024, rising from a valuation of US$1.8 bn in 2015 to US$3.1 bn by 2024. The segment of ECG systems contributed the largest share to the market’s overall revenues in 2015, accounting for nearly US$878 mn in 2015. However, the segment of implantable loop recorder